Mode
Text Size
Log in / Sign up

SPG4 frequency is 33.3% in Central Chinese HSP families with 7 novel SPAST variants identified

SPG4 frequency is 33.3% in Central Chinese HSP families with 7 novel SPAST variants identified
Photo by wu yi / Unsplash
Key Takeaway
Consider SPAST screening in HSP; novel variants in this cohort require functional validation.

This observational cohort study characterized the clinical and genetic profile of hereditary spastic paraplegia type 4 (SPG4) in 63 unrelated families with hereditary spastic paraplegia (HSP) from Central China. Genetic screening was performed using whole exome sequencing to detect SPAST variants, with no comparator group reported. The primary finding was that SPAST variants accounted for 33.3% (21/63) of index patients in this cohort. Secondary outcomes included the identification of 7 novel SPAST variants and the detection of 4 previously reported exon deletions. The mean age of disease onset was 34.0 years, and 2 patients presented with complicated phenotypes, including one case of hyposmia. Safety and tolerability data were not reported. Key limitations were not explicitly stated in the provided evidence, but the study design inherently lacks randomization and a control group. The practice relevance is restrained: the finding that SPAST rearrangement is common suggests it should be considered during genetic analysis for HSP in similar populations, but this is an association only with no causation established. The clinical significance of the novel variants requires functional validation, and the observation of hyposmia as a potential phenotype is based on a single case.

Study Details

Study typeCohort
EvidenceLevel 3
PublishedApr 2026
View Original Abstract ↓
BackgroundMutations in the SPAST gene cause autosomal dominant hereditary spastic paraplegia (HSP) type 4 (SPG4), which is the most common type of HSP with variable frequencies in different ethnic backgrounds. The clinical and genetic characteristics of SPG4 in Central China have not been well documented.MethodsWe screened for SPAST variants by whole exome sequencing in a cohort of 63 unrelated families with HSP from Central China. The clinical manifestations were evaluated.Results21 variants of SPAST were identified in 21 index patients with a frequency of 33.3% (21/63). Seven novel variants were identified, including one missense variant (p.S399W), five frameshift variants (p.Q170Vfs*2, p.S527Vfs*3, p.I605Vfs*17, p.I605Nfs*26, and p.V443Afs*2), and one splicing variant (c.871-1G>A). We also detected four previously reported exon deletions of SPAST. The mean age of disease onset was 34.0 years. Anticipation and variability of disease severity were observed in some autosomal dominant families. Two patients exhibited a complicated phenotype, one of whom presented with hyposmia, which had never been previously reported with SPG4.ConclusionSPG4 is the most common type of HSP in our cohort. Complicated phenotype, although rare, can also be observed in SPG4 patients. The hyposmia might be a new phenotype associated with SPG4. The SPAST rearrangement is common and should be considered during genetic analysis. The novel SPAST variants identified in this study expand the mutational spectrum.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.